Is Harvard Bioscience Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: HBIO) stock is to Strong Buy HBIO stock.
Out of 2 analysts, 1 (50%) are recommending HBIO as a Strong Buy, 1 (50%) are recommending HBIO as a Buy, 0 (0%) are recommending HBIO as a Hold, 0 (0%) are recommending HBIO as a Sell, and 0 (0%) are recommending HBIO as a Strong Sell.
What is HBIO's forecast return on equity (ROE) for 2023-2025?
(NASDAQ: HBIO) forecast ROE is N/A, which is considered weak.
What is HBIO's Price Target?
According to 2 Wall Street analysts that have issued a 1 year HBIO price target, the average HBIO price target is $7.00, with the highest HBIO stock price forecast at $7.00 and the lowest HBIO stock price forecast at $7.00.
On average, Wall Street analysts predict that Harvard Bioscience's share price could reach $7.00 by Jun 22, 2024. The average Harvard Bioscience stock price prediction forecasts a potential upside of 64.32% from the current HBIO share price of $4.26.
What is HBIO's forecast return on assets (ROA) for 2023-2025?
(NASDAQ: HBIO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.16%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.